
News|Articles|October 7, 2025
Pharmacist Takeover: BCMA Bispecifics and CAR T-Cell Therapy
Author(s)Alexandra Gerlach, Associate Editor
Key Takeaways
- Personalized treatment strategies have become central to managing lung cancer brain metastases, improving patient outcomes.
- Targeted therapies and immunotherapies offer more effective, less invasive options compared to traditional methods.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Icotrokinra Outperforms Deucravacitinib in Head-to-Head Psoriasis Study
2
Dato-DXd Shows Promise as First-Line Therapy in Metastatic TNBC
3
Clinical and Public Health Implications of Recent H5N1 Poultry Outbreaks
4
From Policy to Practice: How the ACC Legislative Conference Advances Cardiovascular Care
5